Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 1
1968 1
1969 2
1970 1
1972 2
1973 2
1974 2
1975 1
1978 2
1979 4
1980 1
1981 2
1982 3
1983 1
1984 2
1993 1
1995 1
1996 2
1997 1
1998 1
1999 3
2000 2
2001 2
2003 1
2007 1
2008 1
2018 1
2019 1
2020 2
2021 6
2022 1
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.
Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva GV, Giannini EG, Piscaglia F, Rapaccini G, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Pelizzaro F, Ramirez Morales R, Cillo U, Trevisani F, Miele L, Marchesini G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Vitale A, et al. Gut. 2023 Jan;72(1):141-152. doi: 10.1136/gutjnl-2021-324915. Epub 2021 Dec 21. Gut. 2023. PMID: 34933916
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.
Vitale A, Romano P, Cillo U; Writing Group for the HE.RC.O.LE.S Collaborative Group; Writing Group for the ITA.LI.CA Collaborative Group; HE.RC.O.LE.S and ITA.LI.CA Collaborative Groups; Lauterio A, Sangiovanni A, Cabibbo G, Missale G, Marseglia M, Trevisani F, Foschi FG, Cipriani F, Famularo S, Marra F, Saitta C, Serenari M, Vidili G, Morisco F, Caturelli E, Mega A, Pelizzaro F, Nicolini D, Ardito F, Garancini M, Masotto A, Baroni GS, Azzaroli F, Giannini E, Perri P, Scarinci A, Fontana AP, Brunetto MR, Iaria M, Di Marco M, Nardone G, Dominioni T, Lai Q, Ferrari C, Rapaccini GL, Rodolfo S, Romano M, Conci S, Zoli M, Conticchio M, Zanello M, Zimmitti G, Fumagalli L, Troci A, Germani P, Gasbarrini A, La Barba G, De Angelis M, Patauner S, Molfino S, Zago M, Pinotti E, Frigo AC, Baiocchi GL, Frena A, Boccia L, Ercolani G, Tarchi P, Crespi M, Chiarelli M, Abu Hilal M, Cescon M, Memeo R, Ruzzenente A, Zanus G, Griseri G, Rossi M, Maestri M, Della Valle R, Ferrero A, Grazi GL, Romano F, Giuliante F, Vivarelli M, Jovine E, Torzilli G, Aldrighetti L, De Carlis L. Vitale A, et al. JAMA Surg. 2024 Aug 1;159(8):881-889. doi: 10.1001/jamasurg.2024.1184. JAMA Surg. 2024. PMID: 38771633 Free PMC article.
Anthracyclines.
Mazue G, Williams G, Iatropoulos M, Newman A, Sammartini U, Pulci R, Castellino S, Scampini G, Brughera M, Imondi A, Podesta A. Mazue G, et al. Among authors: imondi a. Int J Oncol. 1996 Mar;8(3):525-36. Int J Oncol. 1996. PMID: 21544392
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival.
Pelizzaro F, Peserico G, D'Elia M, Cazzagon N, Russo FP, Vitale A, Giannini EG, Piccinnu M, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Olivani A, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Trevisani F, Farinati F; Italian Liver Cancer (ITA.LI.CA) Study Group. Pelizzaro F, et al. Dig Liver Dis. 2022 Jul;54(7):927-936. doi: 10.1016/j.dld.2021.08.025. Epub 2021 Sep 25. Dig Liver Dis. 2022. PMID: 34580038
Capecitabine in advanced hepatocellular carcinoma: A multicenter experience.
Pelizzaro F, Sammarco A, Dadduzio V, Pastorelli D, Giovanis P, Soldà C, Rizzato MD, Lombardi G, Lonardi S, Peserico G, Imondi A, Sartori A, Maddalo G, Farinati F. Pelizzaro F, et al. Among authors: imondi a. Dig Liver Dis. 2019 Dec;51(12):1713-1719. doi: 10.1016/j.dld.2019.06.015. Epub 2019 Jul 16. Dig Liver Dis. 2019. PMID: 31320302
Development of inhalational agents for oncologic use.
Sharma S, White D, Imondi AR, Placke ME, Vail DM, Kris MG. Sharma S, et al. Among authors: imondi ar. J Clin Oncol. 2001 Mar 15;19(6):1839-47. doi: 10.1200/JCO.2001.19.6.1839. J Clin Oncol. 2001. PMID: 11251016 Review.
Pattern of macrovascular invasion in hepatocellular carcinoma.
Guarino M, Cucchetti A, Pontillo G, Farinati F, Benevento F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Rodolfo S, Cabibbo G, Marra F, Mega A, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Trevisani F, Giannini EG, Morisco F; ITA.LI.CA Group. Guarino M, et al. Eur J Clin Invest. 2021 Jul;51(7):e13542. doi: 10.1111/eci.13542. Epub 2021 Mar 23. Eur J Clin Invest. 2021. PMID: 33755196
Monofocal hepatocellular carcinoma: How much does size matter?
Pelizzaro F, Penzo B, Peserico G, Imondi A, Sartori A, Vitale A, Cillo U, Giannini EG, Forgione A, Ludovico Rapaccini G, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Svegliati-Baroni G, Giuseppe Foschi F, Olivani A, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Trevisani F, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Pelizzaro F, et al. Among authors: imondi a. Liver Int. 2021 Feb;41(2):396-407. doi: 10.1111/liv.14718. Epub 2020 Nov 23. Liver Int. 2021. PMID: 33155401
55 results